Caricamento...
Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses
We analyzed cost-effectiveness studies related to hematologic malignancies from the Tufts Medical Center Cost-Effectiveness Analysis Registry (www.cearegistry.org), focusing on studies of innovative therapies. Studies that met inclusion criteria were categorized by 4 cancer types (chronic myeloid le...
Salvato in:
| Pubblicato in: | Blood |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society of Hematology
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4366623/ https://ncbi.nlm.nih.gov/pubmed/25655601 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-07-592832 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|